Results 201 to 210 of about 114,754,979 (235)
Some of the next articles are maybe not open access.
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
Movement Disorders, 2002AbstractIn some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop.
Dirk, Dressler, Hans, Bigalke
openaire +2 more sources
[Botulinum toxin Type A. Indications and results].
Revista de neurologia, 2003Since introduction for clinical in the 80s, the botulinum toxin type A is being used with effectiveness in the treatment of different disorders that goes with exaggerated muscular activity. Numerous studies have been demonstrated useful for focal treatment of spasticity.Some indications of the botulinum toxin type A for the treatment of the cerebral ...
Póo P +5 more
openaire +2 more sources
Botulinum toxin type A for the treatment of migraine
Expert Opinion on Pharmacotherapy, 2006Migraine is a common and debilitating disorder that often requires prophylactic therapy, particularly for those migraine patients who meet the diagnostic criteria for chronic daily headache (chronic migraine). Existing prophylactic treatments for migraine are inadequate for many patients due to their modest efficacy and/or systemic side effects ...
openaire +2 more sources
Journal of the American Academy of Dermatology, 2005
Alastair, Carruthers, Jean, Carruthers
openaire +2 more sources
Alastair, Carruthers, Jean, Carruthers
openaire +2 more sources
Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
Toxins, 2021Mark R Baker +2 more
exaly
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
Toxins, 2017Luca Bano +2 more
exaly